These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
358 related articles for article (PubMed ID: 35538578)
1. Tracing the origins of glioblastoma by investigating the role of gliogenic and related neurogenic genes/signaling pathways in GBM development: a systematic review. Shafi O; Siddiqui G World J Surg Oncol; 2022 May; 20(1):146. PubMed ID: 35538578 [TBL] [Abstract][Full Text] [Related]
3. CXCL5 promotes tumorigenesis and angiogenesis of glioblastoma via JAK-STAT/NF-κb signaling pathways. Mao P; Wang T; Du CW; Yu X; Wang MD Mol Biol Rep; 2023 Oct; 50(10):8015-8023. PubMed ID: 37541997 [TBL] [Abstract][Full Text] [Related]
4. Potential Role of JAK-STAT Signaling Pathway in the Neurogenic-to-Gliogenic Shift in Down Syndrome Brain. Lee HC; Tan KL; Cheah PS; Ling KH Neural Plast; 2016; 2016():7434191. PubMed ID: 26881131 [TBL] [Abstract][Full Text] [Related]
5. Constitutive activation of signal transducer and activator of transcription 3 (STAT3) and nuclear factor κB signaling in glioblastoma cancer stem cells regulates the Notch pathway. Garner JM; Fan M; Yang CH; Du Z; Sims M; Davidoff AM; Pfeffer LM J Biol Chem; 2013 Sep; 288(36):26167-26176. PubMed ID: 23902772 [TBL] [Abstract][Full Text] [Related]
6. Massively parallel signature sequencing and bioinformatics analysis identifies up-regulation of TGFBI and SOX4 in human glioblastoma. Lin B; Madan A; Yoon JG; Fang X; Yan X; Kim TK; Hwang D; Hood L; Foltz G PLoS One; 2010 Apr; 5(4):e10210. PubMed ID: 20419098 [TBL] [Abstract][Full Text] [Related]
7. ASCL1 Reorganizes Chromatin to Direct Neuronal Fate and Suppress Tumorigenicity of Glioblastoma Stem Cells. Park NI; Guilhamon P; Desai K; McAdam RF; Langille E; O'Connor M; Lan X; Whetstone H; Coutinho FJ; Vanner RJ; Ling E; Prinos P; Lee L; Selvadurai H; Atwal G; Kushida M; Clarke ID; Voisin V; Cusimano MD; Bernstein M; Das S; Bader G; Arrowsmith CH; Angers S; Huang X; Lupien M; Dirks PB Cell Stem Cell; 2017 Aug; 21(2):209-224.e7. PubMed ID: 28712938 [TBL] [Abstract][Full Text] [Related]
8. Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway. Yu X; Wang M; Zuo J; Wahafu A; Mao P; Li R; Wu W; Xie W; Wang J Life Sci; 2019 Nov; 236():116917. PubMed ID: 31614149 [TBL] [Abstract][Full Text] [Related]
9. Smac mimetic promotes glioblastoma cancer stem-like cell differentiation by activating NF-κB. Tchoghandjian A; Jennewein C; Eckhardt I; Momma S; Figarella-Branger D; Fulda S Cell Death Differ; 2014 May; 21(5):735-47. PubMed ID: 24488095 [TBL] [Abstract][Full Text] [Related]
11. S100A11 functions as novel oncogene in glioblastoma via S100A11/ANXA2/NF-κB positive feedback loop. Tu Y; Xie P; Du X; Fan L; Bao Z; Sun G; Zhao P; Chao H; Li C; Zeng A; Pan M; Ji J J Cell Mol Med; 2019 Oct; 23(10):6907-6918. PubMed ID: 31430050 [TBL] [Abstract][Full Text] [Related]
12. IKK/NF-κB signaling contributes to glioblastoma stem cell maintenance. Rinkenbaugh AL; Cogswell PC; Calamini B; Dunn DE; Persson AI; Weiss WA; Lo DC; Baldwin AS Oncotarget; 2016 Oct; 7(43):69173-69187. PubMed ID: 27732951 [TBL] [Abstract][Full Text] [Related]
13. Regulation of glioblastoma stem cells by retinoic acid: role for Notch pathway inhibition. Ying M; Wang S; Sang Y; Sun P; Lal B; Goodwin CR; Guerrero-Cazares H; Quinones-Hinojosa A; Laterra J; Xia S Oncogene; 2011 Aug; 30(31):3454-67. PubMed ID: 21383690 [TBL] [Abstract][Full Text] [Related]
14. TRIM8: a double-edged sword in glioblastoma with the power to heal or hurt. Hosseinalizadeh H; Mohamadzadeh O; Kahrizi MS; Razaghi Bahabadi Z; Klionsky DJ; Mirzei H Cell Mol Biol Lett; 2023 Jan; 28(1):6. PubMed ID: 36690946 [TBL] [Abstract][Full Text] [Related]
15. Girdin maintains the stemness of glioblastoma stem cells. Natsume A; Kato T; Kinjo S; Enomoto A; Toda H; Shimato S; Ohka F; Motomura K; Kondo Y; Miyata T; Takahashi M; Wakabayashi T Oncogene; 2012 May; 31(22):2715-24. PubMed ID: 22020337 [TBL] [Abstract][Full Text] [Related]
16. Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma. Ashizawa T; Miyata H; Iizuka A; Komiyama M; Oshita C; Kume A; Nogami M; Yagoto M; Ito I; Oishi T; Watanabe R; Mitsuya K; Matsuno K; Furuya T; Okawara T; Otsuka M; Ogo N; Asai A; Nakasu Y; Yamaguchi K; Akiyama Y Int J Oncol; 2013 Jul; 43(1):219-27. PubMed ID: 23612755 [TBL] [Abstract][Full Text] [Related]
17. FAT1 modulates EMT and stemness genes expression in hypoxic glioblastoma. Srivastava C; Irshad K; Dikshit B; Chattopadhyay P; Sarkar C; Gupta DK; Sinha S; Chosdol K Int J Cancer; 2018 Feb; 142(4):805-812. PubMed ID: 28994107 [TBL] [Abstract][Full Text] [Related]
18. RCC2 promotes proliferation and radio-resistance in glioblastoma via activating transcription of DNMT1. Yu H; Zhang S; Ibrahim AN; Wang J; Deng Z; Wang M Biochem Biophys Res Commun; 2019 Aug; 516(3):999-1006. PubMed ID: 31277942 [TBL] [Abstract][Full Text] [Related]
19. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells. Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866 [TBL] [Abstract][Full Text] [Related]
20. TRIM8 regulates stemness in glioblastoma through PIAS3-STAT3. Zhang C; Mukherjee S; Tucker-Burden C; Ross JL; Chau MJ; Kong J; Brat DJ Mol Oncol; 2017 Mar; 11(3):280-294. PubMed ID: 28100038 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]